Market revenue in 2023 | USD 44,281.4 million |
Market revenue in 2030 | USD 76,895.5 million |
Growth rate | 8.2% (CAGR from 2023 to 2030) |
Largest segment | Personalized nutrition & wellness |
Fastest growing segment | PM Therapeutics |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PM Diagnostics, PM Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Illumina Inc, Asure Software Inc, Abbott Laboratories, Danaos Corp, Exact Sciences Corp, Danaher Corp, Amgen Inc, Qiagen NV, Exagen Inc Ordinary Shares, Quest Diagnostics Inc, Biogen Inc, Genelux Corp, International Business Machines Corp, Genentech, 23andMe Holding Co Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to personalized medicine market will help companies and investors design strategic landscapes.
Personalized nutrition & wellness was the largest segment with a revenue share of 34.4% in 2023. Horizon Databook has segmented the Latin America personalized medicine market based on pm diagnostics, pm therapeutics, personalized medical care, personalized nutrition & wellness covering the revenue growth of each sub-segment from 2018 to 2030.
Continuous efforts being made by public and private agencies in Latin America drive the regional market. Continuous advancements in cancer treatments, such as the expansion of less-toxic targeted therapies, improve patients' quality of life in Latin America. However, these advancements are affected by the high cost of cancer treatment, thereby making it challenging for low-income populations.
Several events and conferences in Latin America to raise awareness about personalized and advanced therapies also drive the market. For instance, the 3rd Personalized Medicine Conference held in May 2019 in Mexico focused on advancing proteomic workflows toward precision medicine, transcriptomics for personalized medicine, and other latest advancements in this field.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America personalized medicine market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America personalized medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account